Shen YA, Shyu IL, Lu M, et al. Int J Nanomedicine. 2015; 10:2485–2502.
The authors advise that Figure 2B on page 2490 contains the incorrect image for the EP group. The correct Figure 2B image is shown below.
. 2017 Nov 2;12:8101. doi: 10.2147/IJN.S153053
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [Corrigendum]
Collection date 2017.
© 2017 Shen et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
PMCID: PMC5679671 PMID: 29138565
This corrects the article "Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control" in volume 10 on page 2485.